Poulomi - Sengupta

Dr. Poulomi - Sengupta

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2012 in BMC Cancer
Verified
Journal Article
Open access
PDF file
APAnne-Laure Papa
Anne-Laure Papa
SBSudipta Basu
Sudipta Basu
PSPoulomi - Sengupta
Poulomi - Sengupta
DBDeboshri Banerjee
Deboshri Banerjee
SSShiladitya Sengupta
Shiladitya Sengupta
RHRania Harfouche
Rania Harfouche
Background: Pancreatic cancer remains the deadliest of all cancers, with a mortality rate of 91%. Gemcitabine is considered the gold chemotherapeutic standard, but only marginally improves life-span due to its chemical instability and low cell penetrance. A new paradigm to improve Gemcitabine’s therapeutic index is to administer it in nanoparticles, which favour its delivery to cells when under 500 nm in diameter. Although promising, this approach still suffers from major limitations, as the choice of nanovector used as well as its effects on Gemcitabine intracellular trafficking inside pancreatic cancer cells remain unknown. A proper elucidation of these mechanisms would allow for the elaboration of better strategies to engineer more potent Gemcitabine nanotherapeutics against pancreatic cancer. Methods: Gemcitabine was encapsulated in two types of commonly used nanovectors, namely poly(lactic-co-glycolic acid) (PLGA) and cholesterol-based liposomes, and their physico-chemical parameters assessed in vitro. Their mechanisms of action in human pancreatic cells were compared with those of the free drug, and with each others, using cytotoxity, apoptosis and ultrastructural analyses. Results: Physico-chemical analyses of both drugs showed high loading efficiencies and sizes of less than 200 nm, as assessed by dynamic light scattering (DLS) and transmission electron microscopy (TEM), with a drug release profile of at least one week. These profiles translated to significant cytotoxicity and apoptosis, as well as distinct intracellular trafficking mechanisms, which were most pronounced in the case of PLGem showing significant mitochondrial, cytosolic and endoplasmic reticulum stresses. Conclusions: Our study demonstrates how the choice of nanovector affects the mechanisms of drug action and is a crucial determinant of Gemcitabine intracellular trafficking and potency in pancreatic cancer settings.

12 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
NMNeha Manish Munot
Neha Manish Munot
UKUjjwala Yadav Kandekar
Ujjwala Yadav Kandekar
CRChaitali Rikame
Chaitali Rikame
APAbhinandan PATIL
Abhinandan PATIL
PSPoulomi - Sengupta
Poulomi - Sengupta
ABAnusha Bilal
Anusha Bilal
Thiolation of polymers is one of the most appropriate approaches to impart higher mechanical strength and mucoadhesion. Thiol modification of gum karaya and gum acacia was carried out by esterification with 80% thioglycolic acid. FTIR, DSC and XRD confirmed the completion of thiolation reaction. Anticancer potential of developed thiomer was studied on cervical cancer cell lines (HeLa) and more than 60% of human cervical cell lines (HeLa) were inhibited at concentration of 5 µg/100 µL. Immobilized thiol groups were found to be 0.8511 mmol/g as determined by Ellman’s method. Cytotoxicity studies on L929 fibroblast cell lines indicated thiomers were biocompatible. Bilayered tablets were prepared using Ivabradine hydrochloride as the model drug and synthesized thiolated gums as mucoadhesive polymer. Tablets prepared using thiolated polymers in combination showed more swelling, mucoadhesion and residence time as compared to unmodified gums. Thiol modification controlled the release of the drug for 24 h and enhanced permeation of the drug up to 3 fold through porcine buccal mucosa as compared to tablets with unmodified gums. Thiolated polymer showed increased mucoadhesion and permeation, anticancer potential, controlled release and thus can be utilized as a novel excipient in formulation development.

16 June 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
PKPhanindra Kumar
Phanindra Kumar
PSPoulomi - Sengupta
Poulomi - Sengupta
SBSudipta Basu
Sudipta Basu
Golgi apparatus (GA) is one of the most important sub-cellular organelles involved in cancer. This review describes the recent advancement in development of small molecule probes for illuminating and damaging GA in cancer towards cancer theranostics.

1 January 2026 in ES Chemistry and Sustainability
Verified
Journal Article
Open access
PDF file
PDPratik Diyora
Pratik Diyora
SBSujoy B
Sujoy B
YOYopadhyay
Yopadhyay
PSPoulomi - Sengupta
Poulomi - Sengupta
This review discusses sustainable nanotechnology by critically evaluating Mycogenic green synthesis, addressing scalability challenges, and proposing solutions for eco-friendly industrial translation.